Search page

A 12 months real-life prospective study of lung function in patients with severe eosinophilic asthma undergoing therapy with ics/laba, lama, and anti IL5/5R monoclonal antibody

Assessment of the Efficacy of Mepolizumab in Modulating Disease Activity in Eosinophilic Granulomatosis with Polyangiitis: A 12-Month Analysis Evaluating the Birmingham Vasculitis Activity Score

Association between sputum immunoglobulin E and eosinophilic inflammation regardless of atopic status in asthmatics

Benralizumab effectiveness in severe eosinophilic asthma patients from Central Eastern Europe and Baltics: BREEZE study

Benralizumab reduces annual cumulative OCS dose while improving asthma control and quality of life in severe eosinophilic asthma: Real-World Evidence from the AURORA study

Biologics in Eosinophilic Esophagitis: Current and Future Perspectives

Characteristics of asthma phenotypes: Does coexistence of allergic and eosinophilic asthma increase asthma severity?

Characteristics of pediatric patients with fibrostenotic phenotype of eosinophilic esophagitis: a case series

Characteristics of severe eosinophilic asthma in childhood-onset and adult-onset asthma in U-BIOPRED

Chronic Eosinophilic Sialadenitis Treated Successfully with Dupilumab – A Case Report

Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study

Clinical and histopathologic response following empiric food elimination diet in children with eosinophilic gastritis

Concepts and Pathology of Eosinophilic Rhinosinusitis

Could barrier injury and eosinophilic inflammation contribute to neurological damage in PANS?

Cross-Sectional Real-World Survey of Adult Patients with Eosinophilic Oesophagitis: Symptom Burden and Adaptive Behaviours

Decoding Asthma Therapies: Transcriptomic differences between benralizumab and mepolizumab treatment in patients with severe eosinophilic asthma

Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol

Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis

Dupilumab decreases the number of days with dysphagia in adult and adolescent patients with eosinophilic esophagitis: post hoc analysis of LIBERTY EoE TREET study

Dupilumab for Treatment of Eosinophilic Gastrointestinal Disease in children

Dupilumab improves histologic and endoscopic outcomes in children aged 1–11 with eosinophilic esophagitis: Results from Part A of the Phase 3 EoE KIDS study

Dupilumab treatment leads to clinically meaningful improvements in a range of symptoms and quality of life in patients with eosinophilic esophagitis: Post hoc analysis of LIBERTY EoE TREET

Dupilumab-Induced Diffuse Eosinophilic Drug Rash with Hypereosinophilia in a Patient with Idiopathic Pulmonary Fibrosis and Severe Asthma Exacerbation: A First Case Report

Dysregulation of Peripheral and Airway B Cell Subsets in ANCA Positive Eosinophilic Gralumatosis with Polyangiitis Patients

EAACI & JSA joint symposium : Current topics of allergic and eosinophilic diseases

EAACI & KAAACI Joint Symposium : New Horizons of Allergy & Eosinophilic diseases

Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Polyangiitis (EGPA) patients at time of diagnosis: our experience

Effect of baseline long-acting muscarinic antagonist (LAMA) use on inhaled corticosteroid dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis

Effectiveness of low dose mepolizumab in Korean eosinophilic granulomatosis with polyangiitis (EGPA) patients

Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Efficacy of Benralizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) in a Real-World Setting: Experience at La Paz University Hospital

Efficacy of two years of treatment with anti-IL-5/R therapy for reduction in use of oral glucocorticoids in patients with eosinophilic granulomatosis with polyangiitis

Endotyping in Eosinophilic GI disease

Eosinophilic Chronic Rhinosinusitis with Nasal Polyps : Current Perspective

Eosinophilic Esophagites in cow’s milk allergic patients undergoing baked milk protocol

Eosinophilic Pneumonia Triggered by Toxocara canis in a Patient with Kartagener Syndrome: A Case Report Highlighting Diagnostic Challenges and Interdisciplinary Management

Eosinophilic esophagitis: Exploring local responses, immune mechanisms, and clinical diversity

Eosinophilic esophagitis: clinical approach

Eosinophilic systemic diseases: clinical characterization and efficacy of anti il5/il5-r therapy in a single center italian cohort

Evaluation of the Pediatric Patients with Severe Eosinophilic Asthma Treated with Mepolizumab

Food allergy/Anaphylaxis/Eosinophilic esophagitis

Generalized Acute Eosinophilic Folliculitis Induced by Drugs in an Oncology Patient

Impaired Retinoic Acid Metabolism and Eotaxin Overexpression in Eosinophilic Chronic Rhinosinusitis: Insights into Pathophysiology and Therapeutic Potential of CRABP1 Targeting

Improvement in Lung Function with Rademikibart in Eosinophilic Driven, Type 2 Asthma

Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis

Lichen Planus induced by treatment of severe eosinophilic asthma with biological therapy

Markers of Eosinophilic inflammation in children with food allergy

Measurement of eosinophilic and neutrophilic granule proteins and IgE antibodies in nasal mucosal lining fluid in allergic rhinitis – A pilot study

Mepolizumab Efficacy in Eosinophilic Granulomatosis with Polyangiitis with intractable middle ear effusion: a Case Report

Mepolizumab for eosinophilic granulomatosis with polyangiitis (EGPA): a real-life experience in a single-center cohort

Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology

Monitoring Patients with Severe Eosinophilic Asthma Receiving Benralizumab in Allergy Centers in Greece for 8-12 months – REALISM-A Study (gReek rEAl Life regIStry of benralizuMab among Allergists)

Mucosal vaccine MV130 impairs eosinophilic allergic airway inflammation by restoring local and systemic healthy innate and adaptive immune responses

Outcomes of food reintroduction and identification of food triggers in paediatric eosinophilic gastritis

OverSEA: European Delphi Consensus Study on Best Practices for patients with Severe Eosinophilic Asthma and comorbid CRSwNP

Patients with severe eosinophilic asthma starting anti-IL5 treatment after 2018 have better preserved lung function compared to the patients who started treatment earlier

Predominance of eosinophilic pathogenetic mechanisms in a severe allergic asthma patient on biologic therapy

Real-life experience in eosinophilic granulomatosis with polyangiitis (EGPA) after 12 months with mepolizumab 300mg in specialized autoimmune and asthma units in an Universitary Hospital

Reduction in Annualized Exacerbations with Rademikibart in Eosinophilic Driven, Type 2 Asthma

Reference values of Eosinophilic Derived-Neurotoxin in blood of adults: reasons to use EDTA plasma

Results from the EGPAware Delphi study on Red Flags for Suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): current management in Europe

Selection of Biologics for Severe Pediatric Asthma with Allergic Eosinophilic Phenotype

Severe Eosinophilic Asthma later recognized as EGPA treated with Benralizumab

Severe Eosinophilic Esophagitis: the Key Role of Biologics in Disease Management

Severe asthma or COPD with eosinophilic inflammation? – from uncertainty to remission under anti-IL-5R therapy

The diagnostic value of peripheral blood cell parameters, fractional exhaled nitric oxide, serum total IgE and lung function in eosinophilic asthma

The effect of therapies targeting Type 2 inflammation on Neutrophil Extracellular Traps (NETs) and Extracellular Eosinophilic Traps (EETs) in severe CRSwNP

The impact of intranasal corticosteroids on exhaled nitric oxide in chronic eosinophilic rhinosinusitis with nasal polyposis after surgery

The modulation of ICAM-1 and ICAM-3 is mediated by alarmins in severe eosinophilic asthma

The treatment of eosinophilic asthma with mepolizumab and benralizumab: relative effectiveness

Time to diagnosis among patients with eosinophilic esophagitis: an early cohort study in the US-based TARGET-EGIDs consortium

Allergen and Panallergen Sensitization Profile in Pediatric Eosinophilic Esophagitis Patients: a single centre experience

Are Asymptomatic and Symptomatic Eosinophilic Esophagitis Different Phenotypes in Children?

Baseline Demographics and Disease Characteristics of Pediatric Patients with Eosinophilic Esophagitis (EoE) from the Randomized, Placebo-Controlled, Phase 3 EoE KIDS Study

Being practical in eosinophilic esophagitis

Breaktroughs in Eosinophilic Esophagitis

Characterization of patients with Eosinophilic Esophagitis and response to first-line treatment in a Portuguese Immunoallergology Department

Clinic-pathological characteristics and comorbidities in adult patients with eosinophilic esophagitis in Greece

Clinic-pathological characteristics of eosinophilic esophagitis in children and adolescents in Mexico

Clinical Characteristics and Treatment Response of Eosinophilic Esophagitis in Pediatric Patients: A Descriptive Study from a High-Complexity Colombian Institution

Clinical case: Patient with Inherited epidermolysis bullosa and eosinophilic esophagitis

Clinical characteristics of eosinophilic esophagitis and gastroenteritis in Korean children: a single-center study

Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre

Development of Eosinophilic Esophagitis in a Child with Multiple Food Allergies: The Role of Omalizumab, Oral Immunotherapy and Dietary Incompliance: A Case Report

Diagnosis and management of Eosinophilic Esophagitis

Disease induction in a mouse model of eosinophilic esophagitis is lymphocyte dependent

Disrupted mucosal vascular barrier in adult patients with eosinophilic esophagitis

Dupilumab Is Efficacious in Children Aged 1–11 Years Weighing ≥15 kg With Eosinophilic Esophagitis Irrespective of Individual Atopic Comorbidities: 16-Week Results From the Phase 3 EoE KIDS Study

Dupilumab Treatment Reduces IgE Levels in Patients Aged 2 to 17 Years With Atopic Dermatitis, Asthma, and Eosinophilic Esophagitis

Dupilumab improves histologic, symptomatic, and endoscopic outcomes in children with eosinophilic esophagitis in the EoE KIDS study, regardless of history of elimination diet or concomitant food allergy

Dupilumab improves multiple histopathologic features of eosinophilic esophagitis over 52 weeks: Post hoc analysis of the phase 3 LIBERTY EoE TREET study

Dupilumab is Efficacious in Children (Aged 1 to <12 Years) With Eosinophilic Esophagitis Regardless of Prior History of Comorbidities

Dupilumab normalized the esophageal transcriptome in children aged 1 to <12 years with eosinophilic esophagitis (EoE) in the Phase 3 EoE KIDS trial

Eosinophilic Esophagitis and Atopy: A Shared Mechanism of Type 2 Inflammation

Eosinophilic Esophagitis and Neurodevelopmental Disorders: a potential association requiring further investigations

Eosinophilic Esophagitis and allergic comorbidities

Eosinophilic Esophagitis beyond eosinophils

Eosinophilic Esophagitis in Children: Challenges and Solutions in Dietary Therapy

Eosinophilic diseases: from nasal polyposis, eosinophilic asthma to EGPA (Eosinophilic Vasculitis with PolyAngioitis), evaluation of possible biomarkers of disease evolution

Eosinophilic esophagitis

Eosinophilic esophagitis in children and adolescents: clinical, endoscopic, histologic findings, and response to treatment with: fluticasone, budesonide, proton inhibitors and dupilumab

Eosinophilic esophagitis related to pollen-containing apitherapy and herbal products with Asteraceae flowers: a case report

Exacerbation of eosinophilic esophagitis in a child with seasonal allergic rhinitis during sublingual immunotherapy

Experience of dupilumab in difficult-to-treat eosinophilic esophagitis – A Case Series of 6 Portuguese Patients

Exploring the clinical management of Eosinophilic Esophagitis

Expression of GPR15 and CD38 on peripheral blood pathogenic effector Th2 cells can identify active eosinophilic esophagitis

FIRE Starters: Investigating Food Induced Immediate Esophageal Response in Eosinophilic Esophagitis

First described case of bean-dependent exercise-induced anaphylaxis (AIEDA) associated with eosinophilic esophagitis (EE): presentation of investigation protocol

GPR15L induces chemotaxis of GPR15+ CD4 memory T cells and may facilitate their extravasation into the esophageal mucosa in Eosinophilic Esophagitis (EoE)

IgE-Mediated Food Allergies in Children with Eosinophilic Esophagitis

Immunological Profile of Patients Sensitive to Ipomoea batata Regarding a Case of Eosinophilic Esophagitis

Impact of molecular allergy tests on diagnosis and treatment of eosinophilic esophagitis

Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy

Non IgE-mediated food allergy: from diagnosis to management – Session 2: Eosinophilic esophagitis

Oral allergy syndrome as a marker of food allergy in a monocentric cohort of atopic patients with eosinophilic esophagitis

Plasma Biomarkers Differentiate Active and Inactive Eosinophilic Esophagitis

Potential role of Advanced Glycation End-products in Pediatric Eosinophilic Esophagitis

Safety and effectiveness of Jorveza® in 9 children with eosinophilic esophagitis (EoE)

Surfactants in oral care products may exacerbate Eosinophilic Esophagitis by disrupting epithelial barriers and triggering pro-inflammatory responses

The impaired epithelial barrier function: its interplay with the pathophysiology of eosinophilic esophagitis (EoE)

The link between Food Allergy and Eosinophilic Esophagitis

Tissue-specific inducible expression of IL-33 elicits features of eosinophilic esophagitis

Transcriptomic profiling of the acute response to local esophageal food injections in adult patients with eosinophilic esophagitis

Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis

Ultraprocessed foods induce in situ differentiation of eosinophils in the esophageal mucosa: new insights for the pathogenesis of pediatric eosinophilic esophagitis

Update on eosinophilic esophagitis variants

Age-Dependent Manifestations of Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic esophagitis

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website

Only match titles

What are you looking for?

Knowledge Hub

Event Resources

Task Forces

Sponsored Symposia

Webinars

Courses

Website

Sessions

Working groups